Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
08/2010
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010CA2750967A1 Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2212287A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
08/04/2010EP1709021B1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
08/04/2010EP1497262B1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/04/2010CN101796042A Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates
08/04/2010CN101796026A Guanidine-containing compounds useful as muscarinic receptor antagonists
08/04/2010CN101792422A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2010CN101791394A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767684 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
08/03/2010US7767683 Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
08/03/2010US7767678 treating with hot water; pancreatic and prostate cancer
08/03/2010US7767668 Micronized tanaproget, compositions, and methods of preparing the same
08/03/2010US7767666 Butyl and butynyl benzyl amine compounds
08/03/2010US7767650 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
08/03/2010US7767073 electrooxidation reaction using 2-(N-pyrrolidine)-N,N,N-triethylethanammonium tetrafluoroborate or 3-N-piperidine-N,N,N-triethylammoniopropanesulphonamide tetrafluoroborate; proline final product
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/03/2010CA2306343C Novel aryloxy-alkyl-dialkylamines
07/2010
07/29/2010WO2010084182A1 Methods for making valerenic acid derivatives and their use
07/29/2010WO2010083649A1 Bisarylurea derivatives and their use
07/29/2010WO2010065512A3 Compounds for treating proliferative disorders
07/29/2010WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
07/29/2010US20100190766 Antibacterial agents
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/28/2010EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/28/2010EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists
07/28/2010CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
07/28/2010CN101787002A 1-mustard acyl-4-benzylpiperazine derivative, preparation method thereof and application of anti-free radical or anti-inflammatory activity
07/28/2010CN101133030B Menthane carboxamide derivatives having cooling properties
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids
07/27/2010US7763725 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptors
07/27/2010US7763659 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
07/27/2010US7763639 1-ethyl-4-[2-fluoro-3-(methylsulfonyl)phenyl]piperidine, havinf therapeutic effects against disorders in the central nervous system, such as dyskinesia
07/27/2010US7763618 Pyridyl derivatives and their use as therapeutic agents
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010046908A3 Novel water based process for the preparation of substituted diphenylmethyl piperazines
07/22/2010US20100184600 Stable Ethylene Inhibiting Compounds and Methods for Their Preparation
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010DE102008003826B4 Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze Use of salts as corrosion inhibitors having increased biodegradability, and reduced toxicity, and these salts
07/22/2010CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
07/21/2010CN1886389B Quinoxaline compounds
07/21/2010CN101784522A proton acceptor iminium/carbocation-type coupling agents
07/21/2010CN101781274A Acylated piperazine dipeptidyl peptidase IV inhibitor
07/21/2010CN101781273A dipeptidylpeptidase iv inhibitor containing guanidyl
07/21/2010CN101781272A Method for preparing repaglinide amine and intermediate thereof
07/21/2010CN101781231A Ethylene oligomerization catalyst, preparation method and usage thereof
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759339 such as 1-Phenyl-4-(m-tolylsulfonyl)piperazine, used in the treatment of type-2 diabetes, osteoporosis, hypertension, ocular disorders, cognitive disorders, the metabolic syndrome and other metabolic disorders
07/20/2010US7759331 Pyridine-containing macroheterococylic compounds as kinase inhibitors
07/20/2010US7758730 Method for improving a piperazine colour stability
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2266908C O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/15/2010WO2010080398A1 Sulfonamides as trpm8 modulators
07/15/2010WO2010051935A3 Substituted amido phenoxybenzamides
07/15/2010WO2009098051A8 Aryl sulfonamides as effective analgesics
07/15/2010US20100179326 Benzamide derivative
07/15/2010CA2747662A1 Sulfonamides as trpm8 modulators
07/14/2010EP2205561A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010CN101778814A aldehydes containing hydroxyl groups
07/14/2010CN101774983A Cinepazide maleate compound with novel route
07/14/2010CN101774875A Method for synthesizing piperlongumine compounds
07/13/2010US7754890 Arylsulfones and uses related thereto
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754724 such as 1-Benzyl-4-[(3,5-dimethylisoxazol-4-yl)carbonyl]piperazine, used for controlling fungi and insects; insecticides; fungicides
07/13/2010US7754722 Piperazine derivatives and methods of use
07/08/2010WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators
07/08/2010US20100174074 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
07/08/2010US20100173912 Novel Compound
07/07/2010EP2204363A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
07/07/2010EP2203051A1 Octahydropentalene compounds as chemokine receptor antagonists
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101772491A Repaglinide substantially free of dimer impurity
07/07/2010CN101768140A Preparation method of cinepazide maleate
07/07/2010CN101768139A Piperazine derivative and preparation method and application thereof
07/07/2010CN101768075A 15-carbonyl steviol derivative and salt as well as preparation method and application
07/07/2010CN101215239B Combined preparation method for ethylene diamine and aminoethylpiperazine
07/06/2010USRE41425 Piperazine and piperidine compounds
07/06/2010US7750166 Ionic liquids containing a sulfonate anion
07/06/2010US7750156 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy) piperidine; amination; produced at a high yield and a high purity without using expensive catalysts
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010US7750012 leukotriene A4 hydrolase inhibitors such as 4-{4-[4-(4-Iodo-phenoxy)-phenyl]-piperazin-1-yl]-butyric acid methyl ester, used for the treatment, prevention and/or prophylaxis of inflammatory diseases and disorders
07/01/2010WO2010074052A1 Melanin production inhibitor
07/01/2010WO2010072727A1 New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
07/01/2010WO2010072144A1 Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof
07/01/2010WO2010028842A3 Phenyl malonic acid derivatives
07/01/2010WO2009147389A3 Processes for the synthesis of levocetirizine and intermediates for use therein
07/01/2010US20100168108 Phenyl derivatives and methods of use
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010CA2747770A1 Melanin production inhibitor
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 341